Supporting Treatment and Recovery Over Narcotics for Growth, Empowerment, and Rehabilitation Act STRONGER Act
Impact
If enacted, SB3740 will authorize the allocation of $40 million each year from 2025 to 2029 to implement enhanced treatment programs in residential and correctional settings. The bill mandates that these programs include medication-assisted treatments, recognizing the efficacy of combining medication and behavioral therapies in the recovery process. It places a strong emphasis on training requirements for medical officers and staff at correctional facilities, ensuring they are equipped with the necessary skills and knowledge to manage addiction treatment effectively. This stipulation highlights the growing recognition of the need for qualified personnel in the treatment of inmates with substance use disorders.
Summary
Senate Bill 3740, officially known as the Supporting Treatment and Recovery Over Narcotics for Growth, Empowerment, and Rehabilitation Act (STRONGER Act), aims to amend the Omnibus Crime Control and Safe Streets Act of 1968 by reauthorizing and expanding residential substance use disorder treatment programs. This legislation seeks to address substance use disorders by focusing on rehabilitation rather than punishment, emphasizing the importance of treatment within correctional facilities. By shifting the terminology from 'substance abuse' to 'substance use disorder,' the bill reflects a contemporary understanding of addiction as a health issue rather than solely a criminal one.
Contention
Notable points of contention surrounding SB3740 may arise from differing views on the role of the criminal justice system in addressing addiction. Advocates of the bill argue that providing treatment resources reflects a humane and effective approach to public health and safety, potentially reducing recidivism rates. Critics, however, may express concerns about the implementation of such programs within corrections, questioning their effectiveness and the allocated funding. The ongoing discourse around addiction treatment in the context of incarceration underscores a broader societal debate about the most effective means of addressing substance use and its associated challenges.
Related
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.